Antisense inhibition of hepatitis C virus

Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 245, 4353201, C07H 2104, C12N 1500

Patent

active

060019905

ABSTRACT:
The invention features antisense oligonucleotides and methods of using these antisense oligonucleotides for inhibiting HCV RNA translation.

REFERENCES:
patent: 3625214 (1971-12-01), Higuchi
patent: 4689320 (1987-08-01), Kaji
patent: 4789734 (1988-12-01), Pierschbacher
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5399345 (1995-03-01), Schumacher et al.
patent: 5559028 (1996-09-01), Humphreys
Westermann et al., Biomed. Biochem. Acta, 48(1):85-93, 1989.
Bennet, Science, 271:434, 1996.
Weiss, Science News, 139:108-109, 1991.
Stull et al., Pharmaceutical Research, 12(4):465-483, 1995.
Wu-Pong, Pharmaceutical Technology, 18:102-114, 1994.
Gura, Science, 270;575-577, 1995.
Miller et al., Parasitology Today, 10(3):92-97, 1994.
Rojanasakul, Advanced Drug Delivery Reviews, 18:115-131, 1996.
Brown et al., Secondary Structure of the 5' Nontranslated Regions of Hepatitis C Virus and Pestivirus Genomic RNAs, Nucleic Acids Res., 20:5041-45.
Bukh et al., Sequence analysis of the 5' noncoding region of hepatitis C virus, Proc. Natl. Acad. Sci. USA 89:4942-4946, 1992.
Engelhardt et al., Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver, Proc. Natl. Acad. Sci. USA 91:6196-6200, 1994.
Ghosh et al., Oligodeoxynucleotides as antisense inhibitors of gene expression, Prog. Nuc. Acids Res., 42:79-127, 1992.
Gossen et al., Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA 89:5547-5551, 1992.
Kern, Preclinical Evaluation of Antiviral Agents: In Vitro and Animal Model Testing, Antiviral Agents and Vital Diseases of Man, Raven Press, Ltd., NY, Ch. 3, pp. 87-95, 1990.
Matsukura et al., Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus, Proc. Natl. Acad. Sci. USA 84:7706-7710, 1987.
Milligan et al., Current concepts in antisense drug design, J. Med. Chem. 36(14):1923-1937, 1993.
Uhlmann et al., Antisense Oligonucleotides: A new therapeutic principle, Chemical Reviews 90(4):543-584, 1990.
Von Ruden et al., Inhibition of Human T-Cell Leukemia Virus Type I Replication in Primary Human T Cells that Express Antisense RNA, J. Virology, 63:677-82, 1989.
Wagner, Richard W., Gene inhibition using antisense of oligodeoxynucleotides, Nature 372:333-335, 1994.
Wakita et al., Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides, J. Biol. Chem. 269(19):14205-14210, 1994.
Wolff et al., Direct gene transfer into mouse muscle in vivo, Science 247:1465-1468, 1990.
Benoist et al., In Vivo Sequence Requirements of the SV40 Early Promoter Region, Nature 290:304-10, 1981.
Blum et al., Inhibition of Hepatitis B Virus by Antisense Oligodeoxynucleotides, Lancet 337:1230, 1991.
Brown et al., Secondary Structure of the 5'Nontranslated Regions of Hepatitis C Virus and Pestivirus Genomic RNAs, Nucleic Acids Research 20:5041-5045, 1992.
Choo et al., Genetic Organization and Diversity of the Hepatitis C Virus, Proc. Natl. Acad. Sci. USA 88:2451-2455, 1991.
Crooke, Therapeutic Applications of Oligonucleotides, Annu. Rev. Pharmacol. Toxicol. 32:329-76, 1992.
DeBernardi et al., Inhibition of cAMP Accumulation by Intracellular Calcium Mobilization in C6-2B Cells Stably Transfected with Substance K Receptor cDNA, Proc. Natl. Acad. Sci. USA 88:9257-9261, 1991.
Dolnick, Commentary: Antisense Agents in Pharmacology, Biochemical Pharmacology 40:671-675, 1990.
Goodarzi et al., Antisense Oligodeoxyribonucleotides Inhibit the Expression of the Gene for Hepatitis B Virus Surface Antigen, J. General Virology 71:3021-3025, 1990.
Graham et al., Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, J. Gen. Virology 36:59-72, 1977.
Hamer and Walling, Regulation In Vivo of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors, J. Molecular and Applied Genetics 1:273-288, 1982.
Han et al., Characterization of the Terminal Regions of Hepatitis C Viral RNA: Identification of Conserved Sequences . . . Region and poly(A) Tails at the 3' End, Proc. Natl. Acad. Sci. USA 88:1711-1715, 1991.
Hijikata et al., Gene Mapping of the Putative Structural Region of the Hepatitis C Virus Genome by in Vitro Processing Analysis, Proc. Natl. Acad. Sci. USA 88:5547-5551, 1991.
Hoofnagle et al., Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon, N. Eng. J. Med. 315:1575-1578, 1986.
Inchauspe et al., Genomic Structure of the Human Prototype Strain H of Hepatitis C Virus: Comparison with American and Japanese Isolates, Proc. Natl. Acad. Sci. USA 88:10292-10296, 1991.
Kabanov et al., A New Class of Antivirals: Antisense Oligonucleotides Combined with a Hydrophobic . . . Reproduction and Synthesis of Virus-Specific Proteins in MDCK Cells, Febs Letters, 259:327-330, 1990.
Kiyosawa et al., Interrelationship of Blood Transfusion, Non-A, Non-B Hepatitis and Hepatocellular Carcinoma: Analysis by Detection of Antibody to Hepatitis C Virus, Hepatology 12:671-675, 1990.
Kotin et al., Site-specific Integration by Adeno-associated Virus, Proc. Natl. Acad. Sci. USA 87:2211-2215, 1990.
Kuo et al., An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis, Science 244:362-364, 1989.
Le Doan et al., Antisense Oligonucleotides as Potential Antiviral and Anticancer Agents, Bull. Cancer 76:849-852, 1989.
Lemaitre et al., Specific Antiviral Activity of a Poly(L-lysine)-conjugated Oligodeoxyribonucleotide . . . Vesicular Stomatitis Virus N Protein mRNA Initiation Site, Proc. Natl. Acad. Sci. USA 84:648-652, 1987.
Lisziewicz et al., Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by Antisense Oligonucleotides: An In Vitro Model for Treatment, Proc. Natl. Acad. Sci. USA 89:11209-11213, 1992.
McKnight, Functional Relationships Between Transcriptional Control Signals of the Thymidine Kinase Gene of Herpes Simplex Virus, Cell 31:355-365, 1982.
Morsy et al., Efficient Adenoviral Gene Transduction in Human and Mouse Hepatocytes In Vitro and in Mouse Liver In Vivo, J. Cell. Biochem., Suppl. 17E:SZ109, 1993.
Offensperger et al., In Vivo Inhibition of Duck Hepatitis B Virus Replication and Gene Expression by Phosphorothioate Modified Antisense Oligodeoxynucleotides, Embo J. 12:1257-1262, 1993.
Okamoto et al., Nucleotide Sequence of the Genomic RNA of Hepatitis C Virus Isolated from a Human Carrier: Comparison with Reported Isolates for Conserved and Divergent Regions, J. Gen. Virol. 72:2697-2704, 1991.
Okamoto et al., Full-Length Sequence of a Hepatitis C Virus Genome Having Poor Homology to Reported Isolates: Comparative Study of Four Distinct Genotypes, Virology 188:331-341, 1992.
Rosenberg et al., Gene Transfer into Humans--Immunmotherapy of Patients with Advanced Melanoma, using Lung Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction, N. Eng. J. Med. 323:570-578, 1990.
Smith et al., Antiviral Effect of an Oligo(nucleoside methylphosphonate) Complementary to the Splice . . . Simplex Virus Type 1 Immediate Early pre-mRNAs 4 and 5, Proc. Natl. Acad. Sci. USA 83:2787-2791, 1986.
Spiess, The Asialoglycoprotein Receptor: A Model for Endocytic Transport Receptors, Biochemistry 29:10009-10018, 1990.
Stein and Cheng, Antisense Oligonucleotides as Therapeutic Agents--Is the Bullet Really Magical, Science 261:1004-1012, 1993.
Tsukiyama-Kohara et al., Internal Ribosome Entry Site within Hepatitis C Virus RNA, J. Virology 66:1476-1483, 1992.
Wang et al., Translation of Human Hepatitis C Virus RNA in Cultured Cells is Mediated by an Internal Ribosome-Binding Mechanism, J. Virology 67:3338-3344, 1993.
Wu and Wu, Specific Inhibition of Hepatitis B Viral Gene Expression In Vitro by Targeted Antisense Oligonucleotides, J. Biol. Chem. 267:12436-12439, 1992.
Yoshioka et al., Detection of Hepatitis C Virus by Polymerase Chain Reaction and Response to Interferon-.alpha. Therapy: Relationship to Genotypes of Hepatitis C Virus, Hepatology 16:293-299, 1992.
Zamecnik et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antisense inhibition of hepatitis C virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense inhibition of hepatitis C virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense inhibition of hepatitis C virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-864764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.